Report overview
The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.
This report contains market size and forecasts of HIV Therapeutics in Global, including the following market information:
Global HIV Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global HIV Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of HIV Therapeutics include Boehringer Ingelheim International GmbH, Merck & Co., ViiV Healthcare, AbbVie, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, Gilead Sciences and Johnson & Johnson and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the HIV Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HIV Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global HIV Therapeutics Market Segment Percentages, by Type, 2021 (%)
Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Entry and Fusion Inhibitors
Protease Inhibitors (PIs)
Integrase Inhibitors
Coreceptor Antagonists
Global HIV Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global HIV Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Labs
Global HIV Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global HIV Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HIV Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies HIV Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim International GmbH
Merck & Co.
ViiV Healthcare
AbbVie
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Bristol-Myers Squibb
Gilead Sciences
Johnson & Johnson
Cipla Limited
